Related Experiment Video
Updated: Oct 12, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Factors associated with antibiotic administration delay among preterm infants with late-onset bloodstream infection
M Baczynski1, A Kharrat2, F Zhu3
1Department of Respiratory Therapy, Mount Sinai Hospital, Toronto, ON, Canada.
Insights
Timely antibiotic administration is crucial for reducing mortality in preterm infants with bloodstream infections. Delays are often caused by pre-antibiotic sample collection and difficulties with IV access or fluid boluses.
Area of Science:
- Neonatal Medicine
- Infectious Diseases
- Pediatric Critical Care
Background:
- Late-onset bloodstream infections (BSIs) pose a significant threat to preterm infants.
- Early antibiotic administration is a critical, modifiable factor in reducing BSI-related mortality.
- Identifying factors contributing to delayed antibiotic treatment is essential for improving outcomes.
Purpose of the Study:
- To identify modifiable practice-related factors associated with delayed antibiotic administration in preterm infants with non-coagulase negative staphylococcus bloodstream infections.
Main Methods:
- A cohort study was conducted involving 142 preterm infants diagnosed with non-coagulase negative staphylococcus bloodstream infections.
- Data were collected from two tertiary neonatal intensive care units.
- Factors associated with time to antibiotic administration were analyzed.
Main Results:
- Delays in antibiotic administration were linked to the collection of cerebrospinal fluid or urine samples prior to treatment.
- Difficulty in establishing peripheral intravenous (IV) access contributed to longer times to antibiotics.
- Delayed administration of fluid boluses was also associated with increased time to antibiotic treatment.
Conclusions:
- Pre-antibiotic diagnostic procedures, challenges with IV access, and fluid resuscitation timing are key factors delaying antibiotic administration.
- Targeting these modifiable factors can help reduce treatment delays and improve survival rates for preterm infants with BSIs.
Abstract:
Early antibiotic administration is an important modifiable factor in reducing mortality from late-onset bloodstream infections in preterm infants. In a cohort study including 142 infants with non-coagulase negative staphylococcus bloodstream infection at two tertiary neonatal intensive care units, we identified typical practice-related factors that may be targeted to prevent delays in antibiotic administration. Collection of cerebrospinal fluid or urine sample before administering antibiotics, a longer time taken to site a peripheral intravenous catheter among those without pre-existing access, and a longer time taken to administer fluid boluses were associated with a longer than median time to antibiotic administration.
More Related Videos
07:36Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
08:30One-day Workflow Scheme for Bacterial Pathogen Detection and Antimicrobial Resistance Testing from Blood Cultures
Published on: July 9, 2012
Related Concept Videos
Factors Affecting Drug Response: Overview
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Dosage Interval and Administration Route: Determination Methods
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Factors Affecting Drug Distribution: Miscellaneous Factors
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
Urine Studies II: Urine Culture and Sensitivity Test